Bupropion as a Smoking Cessation Aid in Alcoholics

Completed · Phase 4

Conditions studied: Alcoholism, Smoking

In brief

The purpose of this study is to test the use of time-released bupropion (Wellbutrin) in patients receiving treatment for alcohol abuse/dependence as an aid to stop smoking. Patients will receive either a time-released bupropion or placebo. Both groups will receive nicotine replacement therapy during the 9 week study. A final followup assessment will be conducted 6 months from the start of treatment.

Key facts

Study ID
NCT00044434
Run by
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
People needed
200
Starts
2002-05-01
Expected to finish
2005-04-01
Last updated by the study team
2008-01-29

Who can join

Age: 25 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.